A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	American Society for Clinical investigation 2021-08-01
Σειρά:	JCI Insight
Θέματα:	Immunology Metabolism
Διαθέσιμο Online:	https://doi.org/10.1172/jci.insight.149217

Παρόμοια τεκμήρια

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
ανά: Ingrid G Rekeland, κ.ά.
Έκδοση: (2022-01-01)

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
ανά: Ingrid G. Rekeland, κ.ά.
Έκδοση: (2022-01-01)

Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
ανά: Ingrid G Rekeland, κ.ά.
Έκδοση: (2024-01-01)

Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
ανά: Kari Sørland, κ.ά.
Έκδοση: (2021-03-01)

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
ανά: Øystein Fluge, κ.ά.
Έκδοση: (2015-01-01)

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
ανά: Sigrid Lunde, κ.ά.
Έκδοση: (2016-01-01)

No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
ανά: Marthe Ueland, κ.ά.
Έκδοση: (2022-07-01)

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
ανά: Mella Olav, κ.ά.
Έκδοση: (2009-07-01)

Medical School Education on Myalgic Encephalomyelitis
ανά: Nina Muirhead, κ.ά.
Έκδοση: (2021-05-01)

Myalgic encephalomyelitis - enigma at the medicine’s crossroads
ανά: Pavlović Dragan M., κ.ά.
Έκδοση: (2021-01-01)

Myalgic Encephalomyelitis (ME) or What? An Operational Definition
ανά: Frank Twisk
Έκδοση: (2018-09-01)

Myalgic Encephalomyelitis or What? The International Consensus Criteria
ανά: Frank Twisk
Έκδοση: (2018-12-01)

The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome.
ανά: Maureen R Hanson
Έκδοση: (2023-08-01)

‘The Lightning Process’ and chronic fatigue syndrome/myalgic encephalomyelitis
ανά: Rosamund Vallings
Έκδοση: (2022-01-01)

Restricted Spatial Windows of Visibility in Myalgic Encephalomyelitis (ME)
ανά: Nadia S. Ahmed, κ.ά.
Έκδοση: (2018-01-01)

Visual Aspects of Reading Performance in Myalgic Encephalomyelitis (ME)
ανά: Rachel L. Wilson, κ.ά.
Έκδοση: (2018-08-01)

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
ανά: Øystein Fluge, κ.ά.
Έκδοση: (2011-01-01)

Missing the meaning and provoking resistance; a case of myalgic encephalomyelitis.
ανά: Butler, C, κ.ά.
Έκδοση: (1996)

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome
ανά: Nadja Scherbakov, κ.ά.
Έκδοση: (2020-06-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
ανά: Maria Eugenia Ariza
Έκδοση: (2021-01-01)

Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome
ανά: Alexandra H. Mandarano, κ.ά.
Έκδοση: (2018-01-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?
ανά: Iñigo Murga Gandasegui, κ.ά.
Έκδοση: (2021-09-01)

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome
ανά: Sabine Gravelsina, κ.ά.
Έκδοση: (2022-10-01)

Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
ανά: Daniel Missailidis, κ.ά.
Έκδοση: (2019-07-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
ανά: Mateo Cortes Rivera, κ.ά.
Έκδοση: (2019-08-01)

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
ανά: Lily Chu, κ.ά.
Έκδοση: (2019-02-01)

Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
ανά: Anthony L. Komaroff, κ.ά.
Έκδοση: (2021-01-01)

An Audit of UK Hospital Doctors’ Knowledge and Experience of Myalgic Encephalomyelitis
ανά: Keng Ngee Hng, κ.ά.
Έκδοση: (2021-08-01)

Evaluation of four clinical laboratory parameters for the diagnosis of myalgic encephalomyelitis
ανά: Kenny L. De Meirleir, κ.ά.
Έκδοση: (2018-11-01)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
ανά: Sharpe, M, κ.ά.
Έκδοση: (2021)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
ανά: White, PD, κ.ά.
Έκδοση: (2022)

Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease
ανά: Mawulorm K. I. Denu, κ.ά.
Έκδοση: (2025-01-01)

Tetrahydrobiopterin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Friend or Foe?
ανά: A. F. M. Towheedur Rahman, κ.ά.
Έκδοση: (2025-01-01)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
ανά: D. Peterson, κ.ά.
Έκδοση: (2015-01-01)

Development of an expert system for the classification of myalgic encephalomyelitis/chronic fatigue syndrome
ανά: Fatma Hilal Yagin, κ.ά.
Έκδοση: (2024-03-01)

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome
ανά: Brian Walitt, κ.ά.
Έκδοση: (2024-02-01)

Comparison of T-cell receptor diversity of people with myalgic encephalomyelitis versus controls
ανά: Joshua J Dibble, κ.ά.
Έκδοση: (2024-01-01)

Angina Simultaneously Diagnosed with the Recurrence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
ανά: Koki Li, κ.ά.
Έκδοση: (2021-03-01)

Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
ανά: Alaa Ghali, κ.ά.
Έκδοση: (2022-10-01)

Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
ανά: Santiago Herrera, κ.ά.
Έκδοση: (2018-12-01)